Save the date for our first Synthetic Biology Industrial Translation Showcase
- Posted on 12 March, 2018
Driving the industrial base of the bioeconomy and advanced manufacturing
In recent years the combined expertise and innovation of UK biologists and engineers has catapulted the UK to the position of being amongst the international leaders in the field of synthetic biology/engineering biology. The opportunity today is to drive growth in the UK bioeconomy, potentially worth trillions of pounds globally, by extending knowledge and understanding of the many industries that can benefit from the field.
This event is set to mark a significant milestone in SynbiCITE’s history. Over the last four years SynbiCITE has played a leading role in successfully putting UK synthetic biology/engineering biology on the agenda for industry, investors and policy makers - as a technology that can make a significant economic impact and a positive difference to the world.
World-leading speakers from industry, academia, investors and government will be participating in the meeting. They will deliver fresh insights on the future of engineering biology, its relevance to the UK economy, and the impact our leading businesses are making on the future of health, agriculture, manufacturing, biofuels, water purification and pharmaceutical & medical technologies.
This is an important event. Some of the most influential thought leaders in the field will converge to address fundamental issues affecting businesses in the field today, as well as strategies for investment and growth. This information exchange is an opportunity not to miss.
This, invitation only, event will take place on Tuesday 5th June 2018, at the Royal Academy of Engineering, London 9am-5pm.
Further information will be made available soon.
Share this article:
People also read
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...